NOMURA ASSET MANAGEMENT INTERNATIONAL INC.
Position in NBIX — Neurocrine Biosciences Inc
CIK 921739
PHILADELPHIA, PA
Position in NBIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$37,509,251
+$11,722,332 QoQ
Shares Held
222,554
+13.7% QoQ
Ownership
0.219%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#76
of 768 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026NOMURA ASSET MANAGEMENT INTERNATIONAL INC. holds $328,855,026 across 12 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (11.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SUPN |
Supernus Pharmaceuticals, Inc.
|
2,378,329 | $110,616,081 | |
| 2 | LNTH |
Lantheus Holdings, Inc.
|
671,042 | $74,445,399 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
This page
|
222,554 | $37,509,251 | |
| 4 | ZTS |
Zoetis Inc.
|
385,327 | $27,689,598 | |
| 5 | ANIP |
Ani Pharmaceuticals Inc
|
287,206 | $23,774,912 | |
| 6 | VTRS |
Viatris Inc
|
1,308,106 | $20,772,723 | |
| 7 | ALKS |
Alkermes plc.
|
337,043 | $17,661,053 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
229,581 | $7,959,573 |
All Filings in NBIX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $37,509,251 | 222,554 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $25,786,919 | 195,741 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $36,320,535 | 256,085 | Shares | Defined | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||